Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Managing new-onset gout in pediatric renal transplant recipients: when, how, to what extent.

Assadi F.

J Nephrol. 2013 Jul-Aug;26(4):624-8. doi: 10.5301/jn.5000204. Epub 2012 Aug 30. Review.

PMID:
22941874
2.

Gout in solid organ transplantation: a challenging clinical problem.

Stamp L, Searle M, O'Donnell J, Chapman P.

Drugs. 2005;65(18):2593-611. Review.

PMID:
16392875
3.

Treating gout in kidney transplant recipients.

Baroletti S, Bencivenga GA, Gabardi S.

Prog Transplant. 2004 Jun;14(2):143-7. Review.

PMID:
15264458
4.

Urate-lowering therapy for gout: focus on febuxostat.

Love BL, Barrons R, Veverka A, Snider KM.

Pharmacotherapy. 2010 Jun;30(6):594-608. doi: 10.1592/phco.30.6.594. Review.

PMID:
20500048
5.

Current management of gout in patients unresponsive or allergic to allopurinol.

Bardin T.

Joint Bone Spine. 2004 Nov;71(6):481-5. Review.

PMID:
15589427
6.

Febuxostat for the treatment of hyperuricaemia in people with gout: a single technology appraisal.

Stevenson M, Pandor A.

Health Technol Assess. 2009 Oct;13 Suppl 3:37-42. doi: 10.3310/hta13suppl3/06. Review.

7.

Febuxostat: a new treatment for hyperuricaemia in gout.

Edwards NL.

Rheumatology (Oxford). 2009 May;48 Suppl 2:ii15-ii19. doi: 10.1093/rheumatology/kep088. Review.

PMID:
19447778
8.

Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout.

Bruce SP.

Ann Pharmacother. 2006 Dec;40(12):2187-94. Epub 2006 Nov 28. Review.

PMID:
17132810
9.

2011 recommendations for the diagnosis and management of gout and hyperuricemia.

Hamburger M, Baraf HS, Adamson TC 3rd, Basile J, Bass L, Cole B, Doghramji PP, Guadagnoli GA, Hamburger F, Harford R, Lieberman JA 3rd, Mandel DR, Mandelbrot DA, McClain BP, Mizuno E, Morton AH, Mount DB, Pope RS, Rosenthal KG, Setoodeh K, Skosey JL, Edwards NL.

Phys Sportsmed. 2011 Nov;39(4):98-123. doi: 10.3810/psm.2011.11.1946. Review.

PMID:
22293773
10.

Hyperuricemia, gout and the kidney.

Gibson T.

Curr Opin Rheumatol. 2012 Mar;24(2):127-31. doi: 10.1097/BOR.0b013e32834f049f. Review.

PMID:
22157498
11.

[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].

Fujimori S.

Nihon Rinsho. 2008 Apr;66(4):729-35. Review. Japanese.

PMID:
18409523
12.

Febuxostat: a novel non-purine selective inhibitor of xanthine oxidase for the treatment of hyperuricemia in gout.

Yu KH.

Recent Pat Inflamm Allergy Drug Discov. 2007 Feb;1(1):69-75. Review.

PMID:
19075968
13.
14.

[Treatment of gout].

Dubost JJ, Mathieu S, Soubrier M.

Rev Med Interne. 2011 Dec;32(12):751-7. doi: 10.1016/j.revmed.2011.02.007. Epub 2011 Mar 5. Review. French.

PMID:
21382654
15.

Uric acid and transplantation.

Mazzali M.

Semin Nephrol. 2005 Jan;25(1):50-5. Review.

PMID:
15660335
16.

[Uricosuric agent].

Ohno I.

Nihon Rinsho. 2008 Apr;66(4):743-7. Review. Japanese.

PMID:
18409525
17.
18.

Managing your patient with gout: a review of treatment options.

Doghramji PP.

Postgrad Med. 2011 May;123(3):56-71. doi: 10.3810/pgm.2011.05.2284. Review.

PMID:
21566416
19.

Efficacy and tolerability of febuxostat in hyperuricemic patients with or without gout: a systematic review and meta-analysis.

Ye P, Yang S, Zhang W, Lv Q, Cheng Q, Mei M, Luo T, Liu L, Chen S, Li Q.

Clin Ther. 2013 Feb;35(2):180-9. doi: 10.1016/j.clinthera.2012.12.011. Epub 2013 Jan 16. Review.

PMID:
23332451
20.

Renal transplant-associated hyperuricemia and gout.

Clive DM.

J Am Soc Nephrol. 2000 May;11(5):974-9. Review. No abstract available.

Supplemental Content

Support Center